The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions

CB1 antagonism produces behaviors more consistent with satiety

Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by

Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats

Full article: Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists

Neutral CB1 Receptor Antagonists

Pharmaceuticals, Free Full-Text

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats